Form 4 Filing for Gregoire Sylvie at CervoMed Inc.

Sylvie Gregoire, a 10% owner and director of CervoMed Inc. (CRVO), was granted a stock option to purchase 8,150 shares of common stock on June 8, 2026. This option, granted under the 2025 Equity Incentive Plan, has an exercise price of $2.91 and an expiration date of June 8, 2036. The shares underlying the award will vest monthly over one year, starting June 30, 2026, contingent upon continued service. The transaction was reported on a Form 4 filed on June 10, 2026.